Recursion Pharmaceuticals (RXRX) Price to Sales (2021 - 2026)
Recursion Pharmaceuticals' (RXRX) Price to Sales stood at 35.73 in Q2 2026, up 5.4% from 33.90 a year earlier and up 45.7% from the prior quarter.
Powered by 
Analysis
Recursion Pharmaceuticals (RXRX) Price to Sales (2021 - 2026) Analysis & Trends
For FY2025, Recursion Pharmaceuticals' Price to Sales came in at 28.93, down 36.5% from FY2024.
- Across earlier years, Price to Sales came in at 45.55 in FY2024 (-12.1%), 51.82 in FY2023 (+40.2%), 36.96 in FY2022 (-87.1%) and 286.58 in FY2021.
- Quarterly Price to Sales has ranged from 24.53 in Q1 2026 to 375.42 in Q3 2021 over the past five years.
- On a year-over-year basis, Price to Sales rose in two of the last eight quarters, with an average decline of 6.5%.
- Peak year-over-year performance for Price to Sales in the last five years was growth of 89.9% in Q3 2025, against a decline of 88.8% in Q2 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at 24.53 (Q1 2026), 28.93 (Q4 2025) and 54.93 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn |
| 10 | Recursion Pharmaceuticals | 2.17 Bn | -429.42 Mn | -3.82 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 35.73 |
| Mar 31, 2026 | 24.53 |
| Dec 31, 2025 | 28.93 |
| Sep 30, 2025 | 54.93 |
| Jun 30, 2025 | 33.90 |
| Mar 31, 2025 | 35.96 |
| Dec 31, 2024 | 45.55 |
| Sep 30, 2024 | 28.93 |
| Jun 30, 2024 | 42.46 |
| Mar 31, 2024 | 51.22 |
| Dec 31, 2023 | 51.82 |
| Sep 30, 2023 | 34.94 |
| Jun 30, 2023 | 30.89 |
| Mar 31, 2023 | 27.49 |
| Dec 31, 2022 | 36.96 |
| Sep 30, 2022 | 64.53 |
| Jun 30, 2022 | 77.83 |
| Mar 31, 2022 | 94.60 |
| Dec 31, 2021 | 286.58 |
| Sep 30, 2021 | 375.42 |
API Access
Recursion Pharmaceuticals Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=RXRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "RXRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=RXRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();